Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
No booster dose for pharma sector in Budget 2022
Jignesh Ghelani, Partner, and Sanchita Rungta, Associate Partner, Economic Laws Practice, elucidate all that was expected, but…
DGFT removes restrictions on syringe exports
In 2021, the export of syringes stood at $45.68 million. It was $17.37 million during April-July this fiscal
COVID vaccines induce robust protection against severe disease from Omicron
The research demonstrated that the vaccines induce this protection through cellular immunity or the production of protective…
Alembic Pharma receives US FDA tentative approval for Fesoterodine Fumarate extended-release tablets
The tentatively approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Toviaz extended-release…
Lupin and Axantia enter into license-, supply- and technology-sharing agreement for Pegfilgrastim
Under the terms of the agreement, Axantia will register, distribute and market biosimilar Pegfilgrastim drug product in certain…
Zydus supplies the first consignment of its COVID-19 vaccine ZyCoV-D
ZyCoV-D is a three-dose vaccine administered intradermally using the painless PharmaJet needle-free system, Tropis, on day zero,…
NIH study advances personalised immunotherapy for metastatic breast cancer
In a clinical trial of 42 women with metastatic breast cancer, 28 (or 67 per cent) generated an immune reaction against their…
NAM gains 60 per cent increase in budget 2022
AYUSH Ministry’s budget allocation stands up at Rs 3,050 crores, four-fold increase over seven years
Budget 2022: Industry reacts
Following the announcement of the Union Budget 2022-23 by Nirmala Sitharaman, Finance Minister, let's have a look at what the…
We will have to see the fine print if there is anything for pharma
Kiran Mazumdar Shaw, Chairperson, Biocon, and Biocon Biologics, shares her reaction to the union budget 2022 released today